Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Patrick A. Mayes

At a glance: Patrick A. Mayes is Evp & Chief Scientific Officer at Incyte (INCY). Their latest SEC Form 4, filed Aug 7, 2026, reported a sale of $274K. On file: 0 purchase lines ($0) and 15 sale lines ($6.6M).

Disclosed holdings: about $7.1M of INCY stock: 61,441 shares reported on their latest Form 4 (filed Aug 7, 2026), valued at the Nov 19, 2026 close of $115.96. This counts only INCY shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp & Chief Scientific Officer at Incyte Corp (INCY)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.6M

Patrick A. Mayes's InsiderPrint

15 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Patrick A. Mayes: 15 trades, 2025 to 20262025: 0 buys, 2 sales2026: 0 buys, 13 sales

Reading this print: Almost only sells, trading about 15 times a year, typically $274K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (15)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Chad Michael WhalenEvp, Worldwide Sales · FFIV · 100% match
  2. Emma ReeveDirector · PTCT · 100% match
  3. Daniel Stanley PerottiCFO · PFSI · 100% match
  4. Joshua D. SchmidtGeneral Counsel · IDCC · 99% match
  5. Robert DennehyCOO · MTSI · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Aug 7SEC INCYIncyte Corp Sell Plan 2,20761,441 held (−3%) $123.99 $274K -6.5%
Aug 4SEC INCYIncyte Corp Sell Plan 14,66188,679 held (−14%) $119.46 $1.8M -2.9%
Aug 4SEC INCYIncyte Corp Sell Plan 5,33283,347 held (−6%) $119.42 $637K -2.9%
Aug 4SEC INCYIncyte Corp Sell Plan 2,18781,160 held (−3%) $119.47 $261K -2.9%
Aug 4SEC INCYIncyte Corp Sell Plan 6,17174,989 held (−8%) $119.43 $737K -2.9%
Aug 4SEC INCYIncyte Corp Sell Plan 4,69570,294 held (−6%) $119.39 $561K -2.9%
Aug 4SEC INCYIncyte Corp Sell Plan 2,86467,430 held (−4%) $119.40 $342K -2.9%
Aug 4SEC INCYIncyte Corp Sell Plan 1,64365,787 held (−2%) $119.51 $196K -3.0%
Aug 4SEC INCYIncyte Corp Sell Plan 1,64264,145 held (−2%) $119.38 $196K -2.9%
Aug 4SEC INCYIncyte Corp Sell Plan 8564,060 held (−0%) $122.19 $10K -5.1%
Aug 4SEC INCYIncyte Corp Sell Plan 32663,734 held (−1%) $121.69 $40K -4.7%
Aug 4SEC INCYIncyte Corp Sell Plan 2,29361,441 held (−4%) $119.41 $274K -2.9%
Aug 4SEC INCYIncyte Corp Sell Plan 6,05561,441 held (−9%) $120.43 $729K -3.7%
Dec 12SEC INCYIncyte Corp Sell Plan 5,55360,266 held (−8%) $95.58 $531K +21.3%
Dec 12SEC INCYIncyte Corp Sell Plan 25560,011 held (−0%) $94.94 $24K +22.1%
  • Sell

    Evp & Chief Scientific Officer Patrick A Mayes sold $274K of INCY at $123.99 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Patrick A Mayes sold $1.8M of INCY at $119.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Patrick A Mayes sold $637K of INCY at $119.42 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Patrick A Mayes sold $261K of INCY at $119.47 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Patrick A Mayes sold $737K of INCY at $119.43 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Scientific Officer Patrick A Mayes sold $561K of INCY at $119.39 — pre-scheduled 10b5-1 plan sale.

Follow Patrick A. Mayes

Get one email when Patrick A. Mayes files a new purchase or sale. Free.

At most one email a day about Patrick A. Mayes, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.